Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06131398
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-11-09
Brief Title:
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-09
First Submit QC Date:
November 9 2023
Study First Post Date:
2023-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL